Centessa Pharmaceuticals Plc Stock Analysis

Centessa Stock Analysis Notes

About 96.0% of the company shares are held by institutions such as insurance companies. The book value of Centessa Pharmaceuticals was currently reported as 3.03. The company recorded a loss per share of 2.06. Centessa Pharmaceuticals had not issued any dividends in recent years. Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Centessa Pharmaceuticals plc was incorporated in 2020 and is based in Altrincham, the United Kingdom. Centessa Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 68 people. For more info on Centessa Pharmaceuticals PLC please contact Saurabh MD at 44 203 9206789 or go to https://www.centessa.com.

Centessa Pharmaceuticals Investment Alerts

Centessa Pharmaceuticals Upcoming and Recent Events

Centessa Largest EPS Surprises

View All Earnings Estimates

Centessa Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Centessa Pharmaceuticals Thematic Classifications

Centessa Stock Institutional Investors

Note, although Centessa Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Centessa Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.93 B.

Centessa Profitablity

Management Efficiency

Centessa Pharmaceuticals has return on total asset (ROA) of (0.2682) % which means that it has lost $0.2682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7393) %, meaning that it created substantial loss on money invested by shareholders. Centessa Pharmaceuticals' management efficiency ratios could be used to measure how well Centessa Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of March 28, 2025, Return On Tangible Assets is expected to decline to -0.43. In addition to that, Return On Capital Employed is expected to decline to -0.41. At present, Centessa Pharmaceuticals' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 6.5 M, whereas Total Assets are forecasted to decline to about 374.4 M.

Technical Drivers

As of the 28th of March, Centessa Pharmaceuticals shows the Mean Deviation of 3.04, standard deviation of 3.71, and Risk Adjusted Performance of (0.04). Centessa Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Centessa Pharmaceuticals Price Movement Analysis

Centessa Pharmaceuticals Insider Trading Activities

Centessa Pharmaceuticals Outstanding Bonds

Centessa Pharmaceuticals Predictive Daily Indicators

Centessa Pharmaceuticals Corporate Filings

Centessa Pharmaceuticals Forecast Models

Centessa Pharmaceuticals' time-series forecasting models are one of many Centessa Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Centessa Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Centessa Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Centessa shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Centessa Pharmaceuticals. By using and applying Centessa Stock analysis, traders can create a robust methodology for identifying Centessa entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Centessa analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Centessa analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Centessa Pharmaceuticals PLC stock analysis indicators help investors evaluate how Centessa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Centessa Pharmaceuticals shares will generate the highest return on investment. By understating and applying Centessa Pharmaceuticals stock analysis, traders can identify Centessa Pharmaceuticals position entry and exit signals to maximize returns.

When running Centessa Pharmaceuticals' price analysis, check to measure Centessa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Centessa Pharmaceuticals is operating at the current time. Most of Centessa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Centessa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Centessa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Centessa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.